Tetra Pharm Technologies is a Danish biopharmaceutical company with a mission to improve quality of life for our patients through affordable, high-quality products.
Our vision is to become a leader in research and development of pharmaceutical drugs for the treatment of diseases related to the endocannabinoid system (ECS), such as neuropathic pain, neurological diseases, and mental health disorders.
The endocannabinoid system is a widespread neuromodulatory system that regulates and controls several of the most critical bodily functions, such as learning and memory, emotional processing, sleep, temperature, pain control, inflammatory and immune responses, and appetite.